RxDoctor Payments Data

Daniel Cunningham, DO

Family Medicine · St Petersburg, FLNPI 1831579598

Payments from drug & device makers

$1,801in general payments, 2019–2025

Across 82 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$288
  • AbbVie$201
  • Lilly USA, LLC$169
  • AstraZeneca$162
  • Pfizer$143
  • Phathom Pharmaceuticals, Inc.$126
  • plus $713 from 16 others

What the payments were for

  • Food & beverage$1,801100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,801 in reported general payments places this provider in the 70th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$88,356
Medicare patients
233
Services billed
929

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide57$85,093
EliquisApixaban44$65,790
MounjaroTirzepatide51$52,244
JardianceEmpagliflozin34$33,314
TrulicityDulaglutide29$31,983
FarxigaDapagliflozin Propanediol27$29,669
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$25,522
XareltoRivaroxaban30$23,465
IsentressRaltegravir Potassium12$22,262
JanuviaSitagliptin Phosphate17$12,911
Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf)15$7,733
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$5,966
Atorvastatin Calcium343$3,894
SymbicortBudesonide/Formoterol Fumarate16$3,747
Rosuvastatin Calcium215$3,273

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$288$85,09357 claims
Lilly USA, LLCMounjaro, Trulicity$169$84,22680 claims
PfizerEliquis$143$65,79044 claims
MerckIsentress, Januvia$23$35,17329 claims
AstraZenecaFarxiga, Symbicort$162$33,41643 claims
GSKTrelegy Ellipta, Anoro Ellipta$68$31,48739 claims
Johnson & JohnsonXarelto$46$23,46530 claims
AbbVieSynthroid$201$1,37335 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,282 family medicine providers in Florida.

Other family medicine in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →